Intervention

Insulin Lispro

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 59 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials59
Recruiting0
Common conditions21
Lead sponsors shown13
Advertisement

Clinical trials

59 shown
A Study of LY3938577 in Healthy Participants and Participants With Type 1 Diabetes Mellitus (T1DM)NCT06280703 · 2024-05-15
COMPLETED
A Study of LY8888AX in Participants Using a Connected Insulin Management PlatformNCT05893797 · 2023-10-05
COMPLETED
Efficacy and Safety of THDB0206 Compared to Insulin Lispro Injection in Participants With Type 1 DiabetesNCT07282054 · 2022-04-13
COMPLETED
A Study of LY900014 Versus Insulin Lispro (Humalog) on High Blood Sugar in Participants With Type 1 Diabetes Who Use Insulin PumpsNCT04276207 · 2020-02-25
COMPLETED
Super-Bolus: Effects on Postprandial Glycemia After High Glycemic Index MealNCT04019821 · 2020-01-01
COMPLETED
A Study of LY900027 Given by Insulin Pump to Participants With Type 1 Diabetes MellitusNCT04161976 · 2019-12-27
COMPLETED
The Impact of Two Different Insulin Dose Calculation on Postprandial Glycemia After Mixed Meal.NCT04124302 · 2019-10-01
COMPLETED
A Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 1 DiabetesNCT03952130 · 2019-05-29
COMPLETED
A Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 2 DiabetesNCT03952143 · 2019-05-27
COMPLETED
A Study Comparing LY900014 to Insulin Lispro (Humalog) in Children and Adolescents With Type 1 DiabetesNCT03740919 · 2019-04-07
COMPLETED
A Study of an Automated Insulin Delivery System in Adult Participants With Type 1 DiabetesNCT03890003 · 2019-03-28
COMPLETED
A Study of an Automated Insulin Delivery System in Adult Participants With Type 1 Diabetes MellitusNCT03849612 · 2019-02-21
COMPLETED
A Study of an Automated Insulin Delivery System in Adult Participants With Type 1 Diabetes Mellitus During Meal ChallengesNCT03848767 · 2019-02-20
COMPLETED
A Study of LY900014 in a Medtronic PumpNCT03760640 · 2019-02-18
COMPLETED
A Study Comparing LY900014 to Insulin Lispro (Humalog) in Adults With Type 1 Diabetes Using Insulin Pump TherapyNCT03830281 · 2019-02-14
COMPLETED
A Study of an Automated Insulin Delivery System in Adult Participants With Type 1 Diabetes Mellitus (T1D)NCT03743285 · 2018-11-14
COMPLETED
Simplified Insulin Regimen for the ElderlyNCT03660553 · 2018-10-10
TERMINATED
Azithromycin Insulin Diet Intervention Trial in Type 1 DiabetesNCT03682640 · 2018-09-01
UNKNOWN
A Study of LY900014 in Participants With Type 1 Diabetes MellitusNCT03465878 · 2018-03-26
COMPLETED
A Study of LY2963016 Compared to Lantus® in Adult Chinese Participants With Type 1 Diabetes MellitusNCT03338023 · 2018-03-23
COMPLETED
A Meal Test Study of LY900014 in Participants With Type 1 Diabetes MellitusNCT03449433 · 2018-03-15
COMPLETED
A Study of LY900014 in Japanese Participants With Type 1 Diabetes MellitusNCT03407118 · 2018-02-17
COMPLETED
A Study of a New Type of Insulin in Participants With Type 1 Diabetes on Insulin Injection TherapyNCT02623452 · 2018-01-01
WITHDRAWN
A Study of a New Type of Insulin in Participants With Type 2 Diabetes on Insulin Injection TherapyNCT02623465 · 2018-01-01
WITHDRAWN
A Study of a Novel Insulin Lispro Formulation in Participants With Type 1 Diabetes Mellitus Using Insulin PumpsNCT02623478 · 2018-01-01
WITHDRAWN
Assessment of Mealtime Bolus Insulin BehaviorNCT03368807 · 2017-12-11
COMPLETED
A Comparative Study of LY900014 With Insulin Lispro (Humalog) in Participants With Type 2 Diabetes Mellitus (T2DM)NCT03341312 · 2017-11-13
COMPLETED
A Comparative Study of LY900014 With Insulin Lispro (Humalog) in Participants With Type 1 Diabetes MellitusNCT03341299 · 2017-11-13
COMPLETED
A Study of an Automated Insulin Delivery System in Participants With Type 1 Diabetes Mellitus (T1DM)NCT03367390 · 2017-11-08
COMPLETED
A Comparative Study of LY900014 to Insulin Lispro (Humalog) in Healthy ParticipantsNCT03286751 · 2017-10-13
COMPLETED
A Study of LY900014 in Participants With Type 2 Diabetes MellitusNCT03305822 · 2017-10-11
COMPLETED
Effects of Insulin on Hypotension and SarcopeniaNCT03248271 · 2017-10-01
WITHDRAWN
A Study of LY900014 in Participants With Type 1 DiabetesNCT03214367 · 2017-07-17
COMPLETED
A Study of LY900014 Compared to Insulin Lispro in Participants With Type 2 DiabetesNCT03214380 · 2017-07-14
COMPLETED
A Study of LY900014 in Elderly and Younger Adult Participants With Type 1 Diabetes MellitusNCT03166124 · 2017-05-24
COMPLETED
Feasibility Trial Testing the Bionic Pancreas With ZP4207NCT02971228 · 2016-11-01
COMPLETED
A Study of LY900014 in Participants With Type 2 Diabetes on Insulin Injection TherapyNCT02703337 · 2016-03-01
COMPLETED
A Study of LY900014 Formulation in Participants With Type 1 Diabetes Mellitus Using Insulin PumpsNCT02703324 · 2016-03-01
COMPLETED
A Study of LY900014 in Participants With Type 1 Diabetes on Insulin Injection TherapyNCT02703350 · 2016-03-01
COMPLETED
A Study To Compare the Effects of Insulin Peglispro and Glargine on Insulin Sensitivity and Meal Time Insulin Requirements in Type 2 DiabeticsNCT02197520 · 2014-07-01
COMPLETED
A Study to Compare and Measure the Effects of Insulin Peglispro (LY2605541) and Glargine on Meal Time Insulin RequirementsNCT02152384 · 2014-06-01
COMPLETED
A Study to Compare Pharmacokinetics and Pharmacodynamics of SAR342434 to Insulin Lispro in Subjects With Type 1 DiabetesNCT02273258 · 2013-03-01
COMPLETED
A Study of LY2605541 in Participants With Type 1 Diabetes MellitusNCT01792284 · 2013-02-01
COMPLETED
Immunogenicity Study of Wockhardt's Insulin Lispro/Lispro Mix Basal Bolus Regimen in Type 1 DiabeticsNCT01398670 · 2012-02-01
WITHDRAWN
A Study in Participants With Type I Diabetes MellitusNCT01454284 · 2012-01-01
COMPLETED
A Study in Participants With Type 1 Diabetes MellitusNCT01481779 · 2012-01-01
COMPLETED
A Study in Participants With Type 2 Diabetes MellitusNCT01468987 · 2011-12-01
COMPLETED
Safety and Efficacy Study of Insulin Lispro Versus Insulin Aspart in Participants With Type 2 Diabetes on Insulin Pump TherapyNCT01474538 · 2011-12-01
COMPLETED
A Study in Adults With Type 1 DiabetesNCT01421147 · 2011-08-01
COMPLETED
A Study Comparing Insulin Intensification Therapies in Patients With Type 2 Diabetes MellitusNCT01175811 · 2011-02-01
COMPLETED
A Study in Participants With Type 2 Diabetes Mellitus (AWARD-4)NCT01191268 · 2010-11-01
COMPLETED
A Study on the Effect of 2 Pen Devices on HbA1cNCT00985712 · 2009-10-01
COMPLETED
A Study Evaluating the Bioequivalence of VIAject®7 Compared to VIAject®25 and Comparing the Pharmacokinetic and Pharmacodynamic Properties of VIAject®7 to Insulin Lispro in Subjects With Type 1 Diabetes MellitusNCT01235039 · 2009-07-01
COMPLETED
Safety Study of Subcutaneously-Injected Prandial INSULIN-PH20 NP Compared to Insulin Lispro Injection in Participants With Type 1 Diabetes MellitusNCT00883558 · 2009-05-01
COMPLETED
Pharmacokinetic and Glucodynamic Crossover Study of Subcutaneously (SC) Administered Insulin Lispro + Recombinant Human Hyaluronidase (rHuPH20) and Regular Human Insulin + rHuPH20 Compared to Insulin Lispro AloneNCT00862849 · 2009-03-01
COMPLETED
Effect of Treatment With Insulin VIAjectTM Compared to Regular Human Insulin and Insulin Lispro on Mealtime Blood Vessel Stress in Patients With Type 2 Diabetes Mellitus.NCT00849576 · 2008-04-01
COMPLETED
A Comparison Study of Basal Bolus Therapies Together With Lispro Insulin in Type 2 Diabetes PatientsNCT00666718 · 2008-04-01
COMPLETED
Exubera vs Lispro in a Lantus-based Regimen for Improved Glycemic Control in Type 2 DiabetesNCT00348374 · 2006-06-01
COMPLETED
Comparison of Insulins Aspart and Lispro in Insulin PumpsNCT00461331 · 2004-10-01
COMPLETED

Trial status mix

COMPLETED52
WITHDRAWN5
TERMINATED1
UNKNOWN1

Phase mix

PHASE123
PHASE319
PHASE46
NA5
PHASE25
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.